Jesse I. Treu, 10% Owner at Evoke Pharma Inc (EVOK), sold 5,095 shares at $5.02 ($26K) on 2016-04-27, disclosed to the SEC on 2016-04-27.
Open-market sale of $26k EVOK by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.20 | 1,492 | $8K | 30.0% |
| 2 | $5.02 | 3,603 | $18K | 70.0% |
| Total | $5.07 avg | 5,095 | $26K | 100% |
| Filing → |
| OBLN | BUY | 2018-08-27 | $6.0M | — | Filing → |
| VCYT | SELL | 2018-08-02 | $10.8M | — | Filing → |
| VCYT | SELL | 2017-05-18 | $18K | — | Filing → |